全部

1·The strain of Pseudomonas SIPI-215 has been screened out from371 strains with a rapid plate method, and its cultural conditions were iuvestiga-ted.

通过平板初筛和摇瓶复筛，从371株菌中筛得一株有工业生产价值的胆固醇酯酶产生菌，并对它进行了发酵条件的研究。

2·CONLUSION: Compound SIPI 1 3 and 4 were first reported with new structures, Their lowering cholesterol biosynthesis activities were first found so far.

结论：化合物sipi - 1 - 3和4为首次报道的新结构化合物，抑制胆固醇生物合成活性也为新发现。

3·It showed that 19 strains had anti-MRSA activity. Then we selected a broad spectrum antimicrobial activity of endophytic fungi SIPI 3.0070 to identify strains.

而后我们选取了1株具有广谱抗菌活性的内生真菌SIPI 3.0070进行菌种鉴定，该菌拮抗革兰氏阳性菌（包括MRSA）和真菌。

4·The study on biological activity found that compound SIPI 763 1 showed anti fungal activity and new activity against a methicillin resistant Staphylococus aureus.

生物学活性研究发现，化合物sipi - 763 - 1不仅具有抗真菌活性，还具有抗耐药菌的新活性。

5·In this paper, we validated that Micromonospora purpurea SIPI-A-2020 can produce Gentamicin by strain cultivation, fermentation and extracted Gentamicin from the fermentation broth.

本文通过对绛红色小单孢菌SIPI-A-2020的培养、发酵和初步提取鉴定，验证了绛红色小单孢菌SIPI-A-2020为庆大霉素产生菌。

6·Bio-transforming the canrenone with the enzyme system of Aspergillus ochraceus SIPI-4411; By solvent extraction and silica gel column chromatography, the compound SIPI-CANR was obtained.

应用赭曲霉SIPI-4411的羟化酶系统对化合物坎利酮进行生物转化，通过溶剂萃取、硅胶柱层析，获得转化产物SIPI-CANR化合物的纯品。